Showing results (121-130 of 631) with videos related to
Sort By:
Pageof 64
Nature Medicine|February 15, 2001
Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosisA Angelillo-Scherrer, P de Frutos, C Aparicio, et al.Nature Genetics|September 1, 1997
A mouse model for Zellweger syndromeM Baes, P Gressens, E Baumgart, et al.Annals of the New York Academy of Sciences|April 15, 1997
Insights in vessel development and vascular disorders using targeted inactivation and transfer of vascular endothelial growth factor, the tissue factor receptor, and the plasminogen systemP Carmeliet, L Moons, M Dewerchin, et al.Journal of Thrombosis and Haemostasis : JTH|November 6, 2008
Development of targeted angiogenic medicineS Loges, C Roncal, P CarmelietMolecular and Cellular Endocrinology|June 18, 1990
New perspectives in the function of pituitary folliculo-stellate cellsW Allaerts, P Carmeliet, C DenefEndocrinology|May 1, 1989
The glucocorticoid hormone dexamethasone reverses the growth hormone-releasing properties of the cholinomimetic carbacholP Carmeliet, M Baes, C DenefMolecular and Cellular Endocrinology|May 1, 1989
Stimulation and inhibition of prolactin release from rat pituitary lactotrophs by the cholinomimetic carbachol in vitro. Influence of hormonal environment and intercellular contactsP Carmeliet, P Maertens, C DenefHandbook of Experimental Pharmacology|September 27, 2006
Principles and therapeutic implications of angiogenesis, vasculogenesis and arteriogenesisC Fischer, M Schneider, P CarmelietActa Clinica Belgica|August 4, 2007
Clinical and fundamental aspects of angiogenesis and anti-angiogenesisI Buysschaert, P Carmeliet, M DewerchinNature|September 5, 1996
Role of tissue factor in embryonic blood vessel developmentP Carmeliet, N Mackman, L Moons, et al.Pageof 64